Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-16-079866
Filing Date
2016-02-09
Accepted
2016-02-09 14:07:26
Documents
1
Group Members
JAFCO CO., LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A v431010_sc13ga.htm SC 13G/A 52928
  Complete submission text file 0001144204-16-079866.txt   54738
Mailing Address 8910 UNIVERSITY CENTER DRIVE SUITE 700 San Diego CA 92122
Business Address 8910 UNIVERSITY CENTER DRIVE SUITE 700 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Subject) CIK: 0001394319 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88629 | Film No.: 161398703
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address OTEMACHI FIRST SQUARE, WEST TOWER 11F 1-5-1 OTEMACHI CHIYODA-KU, TOKYO 100-0004 M0 100-0004
Business Address OTEMACHI FIRST SQUARE, WEST TOWER 11F 1-5-1 OTEMACHI CHIYODA-KU, TOKYO 100-0004 M0 100-0004 81-3-5223-7008
JAFCO Super V3 Investment Limited Partnership (Filed by) CIK: 0001590442 (see all company filings)

EIN.: 980581564 | State of Incorp.: M0 | Fiscal Year End: 1231
Type: SC 13G/A